Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ADVAXIS (AMEX: ADXS) | Delayed: 0.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $16.30 | |||
| Open | $0.60 | 52 Week Low | $5.21 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $-4.10 | |||
| Volume | 168,800 | |||||
| Amgen Inc (NASDAQ: AMGN) | Delayed: 439.26 -8.02 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $447.28 | 52 Week High | $176.85 | |||
| Open | $444.40 | 52 Week Low | $133.64 | |||
| Day High | $444.59 | P/E | 66.15 | |||
| Day Low | $439.07 | EPS | $6.64 | |||
| Volume | 2,074,504 | |||||
